MitoRx Therapeutics
PrivateLast Round
pre-Series A
Nov 17, 2025
Momentum Score
50 /100
Company Overview
MitoRx Therapeutics is a biotechnology company developing a new category of innovative small molecule mitochondrial metabolic modulators for weight loss with muscle protection in obesity-related indications and metabolic disease.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine
Business Model
B2B
Customer Profile
Revenue Share, Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
MitoRx Therapeutics Comps
Public and private peers based on sector, stage, and business model.
MitoRx Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| pre-Series A | Nov 17, 2025 | ||||
| Seed | Dec 13, 2023 | ||||
| Seed | Apr 25, 2022 |
MitoRx Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Oshen Holdings SA | pre-Series A |
| Longevitytech.fund | Seed |
| UK Innovation & Science Seed Fund | Seed |
| Wren Capital | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 1, 2026
Presenting data at the American Diabetes Association 2026 conference in June.
- May 17, 2026
Monthly visitors increased 432% MoM.
MitoRx Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about MitoRx Therapeutics's valuation, stock price, and market status.
